GF
BMY icon

GGM Financials’s Bristol-Myers Squibb BMY Stock Holding History

GGM Financials’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5K Hold
269
– – 0.01% 216
2026
Q1 		$16.3K Hold
269
– – 0.01% 186
2025
Q4 		$14.5K Hold
269
– – 0.01% 184
2025
Q3 		$12.1K Buy
+269
New +$12.6K 0.01% 182

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

GGM Financials's BMY Position: Q2 2026 in Review

GGM Financials held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 269 shares worth $15.5K. The position accounts for 0.01% of the portfolio, ranked #216.

GGM Financials first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $16.3K in Q1 2026. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • GGM Financials held 269 shares of Bristol-Myers Squibb worth $15.5K as of Q2 2026.
  • GGM Financials left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of GGM Financials's portfolio in Q2 2026, its #216 holding.
  • GGM Financials first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
  • GGM Financials's Bristol-Myers Squibb position peaked at $16.3K in Q1 2026.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on GGM Financials's 13F filing for Q2 2026, filed 23 Jul 2026.